Cannabidiol may not reduce seizures for adults with drug-resistant epilepsy

Publicly released:
Australia; VIC
Photo by Esteban Lopez on Unsplash
Photo by Esteban Lopez on Unsplash

A study in adults with drug-resistant focal epilepsy has found little evidence that cannabidiol can reduce their seizures. A team of Aussie and international researchers randomised 188 patients to receive either small or large doses of cannabidiol through the skin or placebo over 12 weeks. At the end of the study period, the researchers say there was no significant difference in seizure reduction between the three groups. Over a more long-term follow up period they say seizure rates in the cannabidiol-treated participants were somewhat reduced from what could be expected, suggesting more research using higher doses could be warranted as the medication appeared to be well-tolerated and safe.

Attachments

Note: Not all attachments are visible to the general public. Research URLs will go live after the embargo ends.

Research JAMA, Web page The URL will go live after the embargo ends
Journal/
conference:
JAMA Network Open
Research:Paper
Organisation/s: Monash University, The University of Melbourne
Funder: This clinical trial was supported by Zynerba Pharmaceuticals, Inc, developer of ZYN002
Media Contact/s
Contact details are only visible to registered journalists.